Essity AB stock (SE0009922164): hygiene group updates 2026 outlook after solid Q1

Essity AB recently reported first-quarter 2026 results and updated its 2026 outlook, highlighting pricing, cost savings and portfolio changes as key levers for its global hygiene and health business.

Essity AB, the Swedish hygiene and health company behind brands such as TENA and Tork, has reported its first-quarter 2026 results and updated its outlook for the rest of the year, emphasizing continued price/mix gains, efficiency measures and portfolio optimization as drivers of profitability, according to a company report published on 04/25/2026 and a related press release on the same date from Essity’s investor relations site Essity investor information as of 04/25/2026. In the update, management pointed to easing raw material costs and ongoing restructuring following the exit of its Russian operations as important components of the 2026 financial trajectory, as detailed in Essity’s Q1 2026 earnings press release dated 04/25/2026 Essity press release as of 04/25/2026.

As of: 05/15/2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Essity B
• Sector/industry: Hygiene and health products
• Headquarters/country: Stockholm, Sweden
• Core markets: Europe, North America, Latin America and Asia
• Key revenue drivers: Tissue, incontinence products, professional hygiene and medical solutions
• Home exchange/listing venue: Nasdaq Stockholm (ticker: ESSITY B)
• Trading currency: Swedish krona (SEK)

Essity AB: core business model

Essity AB operates as a global supplier of hygiene and health products, with activities spanning consumer tissue, professional hygiene, incontinence and femcare products, as well as certain medical solutions. The company focuses on everyday-use goods such as paper towels, toilet tissue, diapers and sanitary products sold under well-established international and regional brands, as summarized in its corporate profile on Essity’s website dated 03/01/2026 Essity corporate overview as of 03/01/2026. Its business model combines scale in manufacturing, strong brand portfolios and a wide distribution network spanning retail, healthcare institutions and away-from-home channels.

Within consumer-facing segments, Essity seeks to capture value through brand strength, product innovation and tailored offerings for different regions and demographic groups. The company emphasizes hygiene and health benefits, along with convenience features, as differentiation points compared with private-label or lower-cost alternatives. In professional hygiene, Essity sells dispensers, paper and soap solutions primarily under the Tork brand to workplaces, public venues and industry facilities, leveraging service-oriented solutions and long-term customer relationships, according to an overview of the Tork business on Essity’s site dated 02/15/2026 Essity brand information as of 02/15/2026.

The company’s medical solutions and incontinence businesses further expand the health-related part of the portfolio. TENA and related brands provide incontinence products and services for both consumers and care institutions, while medical offerings include wound care, compression therapy and orthopedic products that are typically sold to hospitals, clinics and specialized distributors. This mix of consumer, professional and healthcare channels diversifies Essity’s revenue streams and exposes the group to demographic tailwinds such as aging populations and rising healthcare needs in many markets, as noted in Essity’s annual and sustainability report for 2025, published on 03/07/2026 Essity annual report as of 03/07/2026.

Main revenue and product drivers for Essity AB

Essity’s main revenue drivers are its large consumer tissue and personal care categories, where sales volumes tend to be relatively stable across economic cycles due to the essential nature of hygiene products. Within these categories, pricing and product mix are important levers, especially in an inflationary environment where the company seeks to offset cost increases in raw materials, energy and logistics. For the full year 2025, Essity highlighted price/mix as a major contributor to organic net sales growth, according to the company’s 2025 annual and sustainability report published on 03/07/2026 Essity annual report as of 03/07/2026. Product innovation, including premium and sustainable variants, also aims to support margins by encouraging trade-up within existing customer bases.

Professional hygiene, centered on the Tork brand, is another significant pillar. Revenue in this segment is driven by demand from offices, hospitality, healthcare and industrial clients, where usage levels correlate with occupancy rates, tourism and overall economic activity. After pandemic-related fluctuations, Essity has noted normalization and growth in away-from-home consumption. The company has additionally focused on digital solutions such as connected dispensers and hygiene management systems, which seek to create customer stickiness and emphasize efficiency and sustainability, as described in an overview of digital innovations on Essity’s website dated 01/30/2026 Essity innovation overview as of 01/30/2026.

Incontinence products and medical solutions, under brands such as TENA and Leukoplast, form a growing part of Essity’s portfolio. These categories can offer higher margins but also require investment in clinical evidence, product development and tailored solutions for healthcare systems. Demand is influenced by demographic trends, healthcare spending and reimbursement policies in key markets. For example, Essity has emphasized its ambition to grow its medical solutions segment both organically and through bolt-on acquisitions, as mentioned in its capital market day materials published on 11/20/2025 Essity capital market day material as of 11/20/2025. Portfolio optimization, including divestments of non-core operations, is also part of the group’s strategy to focus on segments with stronger growth and profitability profiles.

Industry trends and competitive position

Essity operates in global markets that are generally characterized by steady, non-discretionary demand, yet intense competition from multinational peers and private-label producers. Key industry trends include increasing consumer awareness of hygiene, greater focus on sustainability and circularity, and the expansion of healthcare and eldercare services in both mature and emerging markets. Essity has sought to address these trends by committing to environmental targets, such as reducing greenhouse gas emissions in its operations and sourcing more sustainable fiber, as outlined in its 2025 sustainability reporting within the annual report published on 03/07/2026 Essity sustainability report as of 03/07/2026. These efforts aim to align the company with customer and regulatory expectations on climate and resource use.

From a competitive standpoint, Essity faces large international rivals in tissue and personal care, as well as regional producers and private labels that may compete primarily on price. To differentiate, Essity leverages strong brands, innovation and a broad geographic presence. Emerging market expansion is an important component, especially in Latin America and Asia, where rising income levels and urbanization support increased consumption of branded hygiene products. At the same time, the company continues to optimize its manufacturing footprint, seeking efficiency improvements and cost savings that can help defend margins even when pricing power is constrained, which was highlighted as a priority in Essity’s Q1 2026 earnings press release dated 04/25/2026 Essity press release as of 04/25/2026.

For US investors, Essity’s competitive position may be viewed in the context of global hygiene peers listed in North America and Europe. While Essity’s primary listing is on Nasdaq Stockholm and its reporting currency is the Swedish krona, the company has a notable presence in North America through its professional hygiene and health businesses. This provides exposure to structural hygiene and healthcare demand trends in the US market while also introducing currency and cross-border governance considerations that some investors may assess when evaluating non-US listings. Essity has underscored its goal of maintaining an investment-grade profile and offering a competitive shareholder remuneration policy via dividends, as noted in its financial targets section of the 2025 annual report published on 03/07/2026 Essity financial targets information as of 03/07/2026.

Conclusion

Essity AB combines a broad portfolio of hygiene and health products with a global footprint, which together provide diversified exposure to essential consumption and healthcare-related demand. The company’s recent Q1 2026 results and updated outlook for the remainder of the year emphasize pricing, cost efficiencies and portfolio streamlining as levers to navigate input cost fluctuations and competitive pressures, as indicated in Essity’s earnings communication on 04/25/2026 Essity press release as of 04/25/2026. For US investors, the stock offers indirect participation in North American hygiene and healthcare trends through a European-listed company, while also presenting currency and market-structure aspects that may differ from US domestic peers. As always, the balance between defensive demand characteristics, execution on strategic priorities and external cost and regulatory environments remains central when observing the company’s future performance.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.